Fibrobiologics Inc (FBLG) Stock Price, Quote & News

Company Profile

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

Industry: Biotechnology

Sector: Healthcare

Phone: 281-651-5150

Website: www.fibrobiologics.com

Address:

455 East Medical Center Boulevard, Suite 300, Houston, United States

Hassan77 Oct. 3 at 9:28 PM

$FBLG Its crazy how long this has been floating between .50-.60..will this ever begin to move north or make a run??? Moves like a slug honestly..

1 · Reply

Dani_G_German Oct. 2 at 9:24 PM

$FBLG

0 · Reply

leanandmean Oct. 2 at 1:32 AM

$FBLG please watch out for @ThomasIchim this so called doctor has tanked $TSOI $NWBO and a host of other tickers. He is likely in bed with toxic lenders and the names you see pumping your plays are the same ones holding large quantities of notes in most recent 10k

0 · Reply

Hassan77 Oct. 1 at 9:43 PM

$FBLG They hold over 275 patents issued and pending could be a gold mine

0 · Reply

Dani_G_German Oct. 1 at 3:05 PM

$FBLG this is too good to be this too low. Taking advantage and entering before the crowd comes. Good luck 🍀

1 · Reply

Njsloans1 Oct. 1 at 2:56 PM

$FBLG grabbed a bag at these prices.

0 · Reply

DMAIC Oct. 1 at 2:33 PM

$FBLG just saw a commercial on Fox Business and it seemed more focused on advertising its stock ticker than the company itself. 👎🏻

0 · Reply

Hassan77 Oct. 1 at 1:11 AM

$FBLG Set back today...We really need a good PR piece to ignite this company and stock and get it out of this cursed algo chokehold its currently in..

0 · Reply

Dex021 Sep. 30 at 3:52 PM

$FBLG what just happened lolll????

0 · Reply

Hassan77 Sep. 30 at 3:49 PM

$FBLG Not shaking me out with that BS

1 · Reply

FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa

Sep 12, 2025, 8:30 AM EDT - 24 days ago

FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies

Sep 11, 2025, 8:30 AM EDT - 25 days ago

FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment

Sep 10, 2025, 8:30 AM EDT - 26 days ago

FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies

Aug 27, 2025, 8:30 AM EDT - 5 weeks ago

FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Jul 31, 2025, 4:30 PM EDT - 2 months ago

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jul 28, 2025, 8:30 AM EDT - 2 months ago

FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

Jul 11, 2025, 8:30 AM EDT - 3 months ago

FibroBiologics to Present at the Advanced Wound Care Summit USA

Jul 9, 2025, 8:30 AM EDT - 3 months ago

FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank

Jul 7, 2025, 4:35 PM EDT - 3 months ago

FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10

Jun 16, 2025, 4:35 PM EDT - 4 months ago

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

Jun 16, 2025, 9:50 AM EDT - 4 months ago

FibroBiologics to Present at the BIO International Convention 2025

Jun 9, 2025, 8:30 AM EDT - 4 months ago

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

May 16, 2025, 8:30 AM EDT - 5 months ago

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

May 14, 2025, 4:30 PM EDT - 5 months ago

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 29, 2025, 9:15 AM EDT - 5 months ago

FibroBiologics Presenting at the ThymUS 2025 Meeting

Apr 29, 2025, 9:15 AM EDT - 5 months ago

FibroBiologics Presents at the ThymUS 2025 Meeting

Apr 11, 2025, 8:30 AM EDT - 6 months ago

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

Apr 8, 2025, 8:30 AM EDT - 6 months ago

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

Apr 2, 2025, 8:30 AM EDT - 6 months ago

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

Mar 31, 2025, 4:25 PM EDT - 6 months ago

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 27, 2025, 8:30 AM EDT - 6 months ago

FibroBiologics Announces 2025 Annual Meeting of Stockholders

Mar 21, 2025, 8:30 AM EDT - 7 months ago

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

Mar 4, 2025, 8:30 AM EST - 7 months ago

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

Feb 27, 2025, 8:30 AM EST - 7 months ago

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

Feb 5, 2025, 9:15 AM EST - 8 months ago

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

Dec 30, 2024, 4:30 PM EST - 10 months ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

Dec 30, 2024, 2:12 PM EST - 10 months ago

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

Dec 23, 2024, 7:55 AM EST - 10 months ago

FibroBiologics Announces $25 Million Financing

Nov 19, 2024, 9:15 AM EST - 11 months ago

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

Nov 14, 2024, 9:15 AM EST - 11 months ago

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

Nov 12, 2024, 4:20 PM EST - 11 months ago

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 29, 2024, 9:15 AM EDT - 1 year ago

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

Oct 28, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

Oct 18, 2024, 8:30 AM EDT - 1 year ago

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

Oct 16, 2024, 9:15 AM EDT - 1 year ago

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

Oct 11, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

Sep 30, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

Sep 19, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Engages Southern Star Research as CRO in Australia

Sep 12, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

Sep 6, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 20, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

Aug 7, 2024, 6:52 PM EDT - 1 year ago

FibroBiologics Files 2024 Second Quarter Report

Jul 15, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

Jun 25, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

Jun 13, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Set to Join Russell 2000® Index

Jun 6, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

May 15, 2024, 4:30 PM EDT - 1 year ago

FibroBiologics Announces 2024 Annual Meeting of Stockholders

May 14, 2024, 5:24 PM EDT - 1 year ago

FibroBiologics Files 2024 First Quarter Report

May 7, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at the BIO International Convention 2024

Hassan77 Oct. 3 at 9:28 PM

$FBLG Its crazy how long this has been floating between .50-.60..will this ever begin to move north or make a run??? Moves like a slug honestly..

1 · Reply

Dani_G_German Oct. 2 at 9:24 PM

$FBLG

0 · Reply

leanandmean Oct. 2 at 1:32 AM

0 · Reply

Hassan77 Oct. 1 at 9:43 PM

$FBLG They hold over 275 patents issued and pending could be a gold mine

0 · Reply

Dani_G_German Oct. 1 at 3:05 PM

$FBLG this is too good to be this too low. Taking advantage and entering before the crowd comes. Good luck 🍀

1 · Reply

Njsloans1 Oct. 1 at 2:56 PM

$FBLG grabbed a bag at these prices.

0 · Reply

DMAIC Oct. 1 at 2:33 PM

$FBLG just saw a commercial on Fox Business and it seemed more focused on advertising its stock ticker than the company itself. 👎🏻

0 · Reply

Hassan77 Oct. 1 at 1:11 AM

$FBLG Set back today...We really need a good PR piece to ignite this company and stock and get it out of this cursed algo chokehold its currently in..

0 · Reply

Dex021 Sep. 30 at 3:52 PM

$FBLG what just happened lolll????

0 · Reply

Hassan77 Sep. 30 at 3:49 PM

$FBLG Not shaking me out with that BS

1 · Reply

Hassan77 Sep. 30 at 3:47 PM

$FBLG Added more on that dip

0 · Reply

GladysFoster Sep. 30 at 10:40 AM

$FBLG let's go people

0 · Reply

Hassan77 Sep. 29 at 9:41 PM

$FBLG Going to add another couple thousand shares tomorrow

1 · Reply

Hassan77 Sep. 29 at 9:41 PM

$FBLG My confidence is beginning to grow and am optimistic for a significant run with clinical trial data fast approaching. Volume is beginning to increase and price movement has been more volatile to the upside.

0 · Reply

Hassan77 Sep. 29 at 4:04 PM

$FBLG Almost ready for 🚀🚀

0 · Reply

Statwell7 Sep. 29 at 3:52 PM

$FBLG

0 · Reply

GladysFoster Sep. 29 at 9:12 AM

$FBLG when's this run coming then??

0 · Reply

Cookem_up09 Sep. 28 at 5:03 PM

$FBLG this week needs to keep the new floor of .62 then continue to move up til the trial news comes out.

0 · Reply

DikinYoFace Sep. 28 at 12:55 PM

$FBLG 🤫 0.50 dip was great, keep stacking those new floors, we're ready to go up.

0 · Reply

Dex021 Sep. 26 at 7:36 PM

$FBLG as a bull can

0 · Reply

Hassan77 Sep. 25 at 8:38 PM

$FBLG Management had an opportunity today to drop news and prevent the sell off back under .60 but they seem to be mute and allergic to updating their shareholders. Most bio stocks have bounced off their bottom support except for Fibro..

1 · Reply

GladysFoster Sep. 25 at 4:44 PM

$FBLG Make or break, big drop or onwards and upwards?????

0 · Reply

Market Cap	23.01M
Revenue (ttm)	0.00
Net Income (ttm)	-11.16M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	9.38

Volume	835,100
Avg Vol	587,888
Day's Range	N/A - N/A
Shares Out	41.89M
Stochastic %K	36%
Beta	-0.68
Analysts	Strong Sell
Price Target	$10.25